The South Dakota Republican has a track record on telehealth, supporting rural hospitals, accountability for pharmacy benefit ...

With full control of the House and Senate, President-elect Trump and his fellow Republicans have the power to assert their ...

Under the current system, PBMs act as middlemen between manufacturers, insurers and pharmacies - inflating drug prices at the expense of patients with complex rebate and pricing structures. In ...

Steve Anderson said there remains an urgent need for the current 118th Congress to reform the tactics of market-dominant ...

Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus, ...

The "middlemen of medicine" have become obstacles to progress, often perpetuating inefficiencies and exacerbating healthcare's existing problems.

Congresswoman Nikki Budzinski (IL-13) will host a roundtable discussion with independent pharmacists on Saturday, November 2, ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story PBM reform push heats up Congress is ...

It remains to be seen how well President Joe Biden’s Inflation Reduction Act will actually work in lowering prescription drug ...

PBMs represent insurers in drug transactions, and they decide which medicines will be covered. And, because just three PBMs control access to about 80% of insured patients, they have enormous ...

One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company ...